1977
DOI: 10.1007/978-1-4757-0719-9_12
|View full text |Cite
|
Sign up to set email alerts
|

Pepstatin Inhibition Mechanism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
38
0
1

Year Published

1983
1983
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(40 citation statements)
references
References 18 publications
1
38
0
1
Order By: Relevance
“…In contrast, the naturally occurring peptide isovaleryl-pepstatin, which contains a central statine moiety as the transition state analogue occupying the P 1 -P 1 Ј positions in the acylated pentapeptide (35), showed subnanomolar potency as an inhibitor of recombinant cyprosin (inhibitor 1 in Table II). Whereas this response might perhaps have been expected as typical of an aspartic proteinase (30), a completely distinct acylated pentapeptide (inhibitor 2; Table II) was almost as effective as an inhibitor of cyprosin, despite having only the central statine residue in common with the sequence of isovaleryl pepstatin.…”
Section: Fig 4 Schematic Representation Of Processing Events In Pmentioning
confidence: 98%
“…In contrast, the naturally occurring peptide isovaleryl-pepstatin, which contains a central statine moiety as the transition state analogue occupying the P 1 -P 1 Ј positions in the acylated pentapeptide (35), showed subnanomolar potency as an inhibitor of recombinant cyprosin (inhibitor 1 in Table II). Whereas this response might perhaps have been expected as typical of an aspartic proteinase (30), a completely distinct acylated pentapeptide (inhibitor 2; Table II) was almost as effective as an inhibitor of cyprosin, despite having only the central statine residue in common with the sequence of isovaleryl pepstatin.…”
Section: Fig 4 Schematic Representation Of Processing Events In Pmentioning
confidence: 98%
“…This transformation causes the geometry at the centre to change from sp 2 to sp 3 [205]. Established inhibitors, consist of part molecules, that mimic a crucial stretch of the protease recognition site and most importantly provide a sequence that duplicates the transition centre sterically without including a cleavable bond [206].…”
Section: Hiv Protease Inhibitorsmentioning
confidence: 99%
“…Pepstatin (101), which contains the unusual amino acid statine, (3S,4S)-4-amino-3-hydroxy-6-methylheptanoic acid, and is proposed to be a transition state analog (63), universally inhibits the members of the aspartic proteinase family, evidence that supports the view that these enzymes all have a similar mechanism of action.…”
Section: Inhibitor Binding Studiesmentioning
confidence: 99%